Life Insurance Company Lending

Life insurance companies lend a portion of their long-term investment portfolios into commercial real estate, and their underwriting reflects that mandate: they are the most conservative lender type in the market, prioritizing capital preservation over yield.

Life companies lend at low leverage — typically 50-65% LTV — well below what a bank, agency lender, or CMBS shop might offer on the same property. In exchange for taking on less risk, they can offer the lowest interest rates of any lender type, on a non-recourse basis.

Life insurance companies want the safest, highest-quality buildings — Class-A assets in major cities. They are selective about both the asset and the market, favoring properties with the strongest tenants, the best locations, and the most predictable long-term cash flow.

This lender type is best for trophy, low-risk core assets — the kind of institutional-quality building an owner intends to hold for the long term, not a value-add project or a secondary-market asset. If a deal doesn't fit that profile, a life insurance company is unlikely to be the right call.

One thing that surprises people new to this market: most life-company CRE loan volume isn't originated by the insurer's own staff calling on borrowers. It flows through a small network of national correspondent mortgage-banking firms, each authorized to originate to a specific insurer's published allocation guidelines — sourcing deals, underwriting them to that insurer's standards, and closing in the insurer's name. Correspondents frequently retain life-of-loan servicing for a fee, which is part of their economic model, not just a courtesy to the insurer.

This matters practically: an insurer's quarterly appetite for a given property type or market is usually communicated through its correspondents rather than through direct outreach, which is why an originator or broker approaches this capital through a correspondent's local office — not a cold call to the insurance company itself.